Clinical Trial Update: The Use of International GerdQ Questionnaire

View source ↗

Summary

A completed clinical trial sponsored by AstraZeneca evaluated the use of the International GerdQ questionnaire in relation to gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED